Sumitomo Life Insurance CO Amgen Inc Transaction History

Sumitomo Life Insurance CO

$5.08 Billion
Q3 2024

A detailed history of Sumitomo Life Insurance CO transactions in Amgen Inc stock. As of the latest transaction made, Sumitomo Life Insurance CO holds 5,928 shares of AMGN stock, worth $1.66 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

5,928

Previous 5,785 2.47%

Holding current value

$1.66 Million

Previous $1.81 Million 5.7%

% of portfolio

0.04%

Previous 0.04%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 16, 2024	BUY	$309.38 - $337.38 $44,241 - $48,245	143 Added 2.47%	5,928 $1.91 Million
Q2 2024 Jul 19, 2024	SELL	$262.75 - $319.31 $196,274 - $238,524	-747 Reduced 11.44%	5,785 $1.81 Million
Q1 2024 Apr 26, 2024	SELL	$268.87 - $324.56 $70,712 - $85,359	-263 Reduced 3.87%	6,532 $1.86 Million
Q4 2023 Jan 30, 2024	SELL	$255.7 - $288.46 $88,727 - $100,095	-347 Reduced 4.86%	6,795 $1.96 Million
Q3 2023 Oct 23, 2023	SELL	$218.65 - $271.46 $20,115 - $24,974	-92 Reduced 1.27%	7,142 $1.92 Million
Q2 2023 Jul 20, 2023	SELL	$214.27 - $253.37 $131,776 - $155,822	-615 Reduced 7.84%	7,234 $1.61 Million
Q1 2023 Apr 27, 2023	SELL	$225.79 - $275.2 $13,095 - $15,961	-58 Reduced 0.73%	7,849 $1.9 Million
Q4 2022 Jan 17, 2023	SELL	$229.03 - $291.01 $36,415 - $46,270	-159 Reduced 1.97%	7,907 $2.08 Million
Q3 2022 Oct 31, 2022	SELL	$224.46 - $253.15 $221,317 - $249,605	-986 Reduced 10.89%	8,066 $1.82 Million
Q2 2022 Jul 22, 2022	BUY	$230.71 - $256.74 $41,066 - $45,699	178 Added 2.01%	9,052 $2.2 Million
Q1 2022 Apr 27, 2022	SELL	$219.27 - $242.57 $36,179 - $40,024	-165 Reduced 1.83%	8,874 $2.15 Million
Q4 2021 Feb 04, 2022	SELL	$198.88 - $227.6 $48,526 - $55,534	-244 Reduced 2.63%	9,039 $2.03 Million
Q3 2021 Oct 25, 2021	SELL	$212.27 - $248.7 $83,422 - $97,739	-393 Reduced 4.06%	9,283 $1.97 Million
Q2 2021 Jul 20, 2021	SELL	$233.58 - $259.14 $348,968 - $387,155	-1,494 Reduced 13.38%	9,676 $2.36 Million
Q1 2021 Apr 27, 2021	SELL	$221.91 - $258.6 $1.07 Million - $1.25 Million	-4,834 Reduced 30.2%	11,170 $2.78 Million
Q4 2020 Feb 05, 2021	SELL	$216.38 - $257.67 $323,920 - $385,731	-1,497 Reduced 8.55%	16,004 $3.68 Million
Q3 2020 Oct 29, 2020	SELL	$234.65 - $260.95 $311,380 - $346,280	-1,327 Reduced 7.05%	17,501 $4.45 Million
Q2 2020 Jul 22, 2020	SELL	$197.81 - $242.74 $322,628 - $395,908	-1,631 Reduced 7.97%	18,828 $4.44 Million
Q1 2020 May 01, 2020	BUY	$182.24 - $241.7 $52,485 - $69,609	288 Added 1.43%	20,459 $4.15 Million
Q4 2019 Jan 24, 2020	BUY	$189.21 - $243.2 $214,374 - $275,545	1,133 Added 5.95%	20,171 $4.86 Million
Q3 2019 Oct 24, 2019	SELL	$174.11 - $208.62 $418,038 - $500,896	-2,401 Reduced 11.2%	19,038 $3.68 Million
Q2 2019 Jul 26, 2019	BUY	$166.7 - $195.41 $146,862 - $172,156	881 Added 4.29%	21,439 $3.95 Million
Q1 2019 Apr 17, 2019	SELL	$180.87 - $203.88 $420,703 - $474,224	-2,326 Reduced 10.16%	20,558 $3.91 Million
Q4 2018 Jan 24, 2019	BUY	$178.4 - $208.25 $96,871 - $113,079	543 Added 2.43%	22,884 $4.46 Million
Q3 2018 Oct 18, 2018	SELL	$185.29 - $208.89 $70,595 - $79,587	-381 Reduced 1.68%	22,341 $4.63 Million
Q2 2018 Jul 23, 2018	BUY	$166.05 - $186.51 $152,599 - $171,402	919 Added 4.22%	22,722 $4.19 Million
Q1 2018 Apr 27, 2018	SELL	$169.43 - $198.0 $162,652 - $190,080	-960 Reduced 4.22%	21,803 $3.72 Million
Q4 2017 Feb 01, 2018	SELL	$168.79 - $188.59 $187,019 - $208,957	-1,108 Reduced 4.64%	22,763 $3.96 Million
Q3 2017 Oct 17, 2017	BUY	$167.29 - $191.0 $3.99 Million - $4.56 Million	23,871	23,871 $4.45 Million

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sumitomo Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Sumitomo Life Insurance CO with notifications on news.

Account

Sumitomo Life Insurance CO Amgen Inc Transaction History